Skip to content
stoqly

Sensient Technologies

SXT NYSE Specialty Chemicals Financials FY2016–FY2025

Sensient Technologies' revenue rose 3.5% to $1.6 billion in fiscal 2025. Its operating margin was 12.8%, up from 12.3% a year earlier. Free cash flow was $38 million, down 60.8%. It paid out $70 million in dividends and buybacks, 181% of free cash flow. The diluted share count rose 0.5%.

Last close Β· Oct 23, 2026

$132.65

1.3%
Revenue Total sales reported in the income statement.
$1.6B
3.5% vs prior year
Operating margin Operating income as a share of revenue.
12.9%
0.5 pts
Net income Profit after all expenses, interest and tax.
$135M
7.9%
Free cash flow Cash from operations minus capital spending.
$38.4M
60.8%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
8.9%
0.1 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$5.7B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
35.8x
On $3.71 EPS (TTM)

What Sensient Technologies does

No business description yet.

Legal name
Sensient Technologies Corp
Fiscal year ends
December 31, 2025
Latest annual report
β€”
Accession Β· CIK
0001140361-26-005311
0000310142

Revenue and margins

Sensient Technologies had $1.6B of revenue in fiscal 2025, up 3.5% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 1.3% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $38.4M in fiscal 2025, 2.4% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Sensient Technologies returned $69.6M to shareholders in fiscal 2025, 181% of free cash flow. The diluted share count rose 0.5%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Sensient Technologies yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$673M and divides by 42.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 35.8x Β· peers 27.8x Β· sector 20.1x.

Balance sheet

Cash, debt and the ratios that show how comfortably Sensient Technologies can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $25.7M$20.9M$28.9M$26.6M$36.5M
Debt incl. finance leases $512M$631M$645M$614M$709M
Net debt / EBITDA 2.2x2.5x2.9x2.3x2.5x
Debt / equity 0.6x0.6x0.6x0.6x0.6x
Interest coverage 13.6x13.5x6.2x6.7x7.0x
Current ratio 3.2x3.4x4.0x3.6x4.1x
Quick ratio 1.4x1.4x1.4x1.3x1.5x
Total assets $1.7B$2.0B$2.0B$2.0B$2.2B
Total liabilities $807M$982M$961M$963M$1.1B
Shareholders' equity $938M$1,000M$1.1B$1.1B$1.2B
Net debt (βˆ’ = net cash) $486M$610M$616M$587M$673M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.3M

2 insiders

Sold, 12 months

$234M

5 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Aug 5, 2026 Mario FerruzziDirector Sold 1,200 $129.48 $0.2M Form 4
May 18, 2026 Thierry HoangVP, Asia Pacific Group Sold 400 $115.19 $0.0M Form 4
May 4, 2026 Thierry HoangVP, Asia Pacific Group Sold 439 $114.15 $0.1M Form 4
Apr 30, 2026 Anstalt Winder10% owner Sold 2,127,566 $109.69 $233M Form 4
Apr 30, 2026 Steven B MorrisPresident, Color Group Sold 200 $114.58 $0.0M Form 4
Dec 3, 2025 Essie WhitelawDirector Sold 3,985 $95.02 $0.4M Form 4
Nov 20, 2025 Essie WhitelawDirector Sold 533 $93.22 $0.0M Form 4
Nov 4, 2025 David J. PlautzVP and Treasurer Bought 2,150 $92.98 $0.2M Form 4
Nov 3, 2025 Joseph CarleoneDirector Bought 1,000 $91.26 $0.1M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ• βœ“ βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ•
Debt fell relative to assets βœ“ βœ“ βœ•
Current ratio rose βœ“ βœ• βœ“
Share count didn't rise βœ• βœ• βœ•
Gross margin rose βœ• βœ“ βœ“
Revenue rose relative to assets βœ• βœ“ βœ“
F-score 5 / 97 / 96 / 9
Accruals ratio βˆ’3.8%βˆ’1.6%0.3%
Altman Z'' 6.746.906.89

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Sensient Technologies SXT $5.7B 3.5% 12.9% 2.4% 8.9% 35.8x 6
Innospec IOSP $2.4B βˆ’3.7% 7.3% 5.0% 11.1% 20.1x 6 Compare β†’
Quaker Chemical KWR $2.7B 2.7% 2.8% 4.3% 1.3% 27.8x 5 Compare β†’
Minerals Technologies MTX $2.0B βˆ’2.2% 2.3% 4.2% 1.6% β€” 4 Compare β†’
Ingevity NGVT $2.5B βˆ’2.7% 35.9% 23.4% 24.6% 46.4x 6 Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $1.4B $1.4B $1.4B $1.3B $1.3B $1.4B $1.4B $1.5B $1.6B $1.6B
Gross profit $513M $510M β€” β€” $424M $455M $489M $460M $507M $539M
Research and development $40.9M $40.9M $43.0M $40.1M $38.5M $34.3M $42.2M $48.1M $49.1M $52.9M
Operating income $186M $168M $203M $121M $153M $170M $197M $155M $192M $207M
Interest expense $18.3M $19.4M $21.9M $20.1M $14.8M $12.5M $14.5M $25.2M $28.8M $29.6M
Pretax income $167M $148M $182M $101M $138M $158M $182M $130M $163M $178M
Income tax $44.4M $58.8M $24.2M $19.0M $28.4M $38.7M $41.3M $36.5M $38.1M $43.1M
Net income $126M $89.6M $157M $82.0M $110M $119M $141M $93.4M $125M $135M
Diluted EPS $2.82 $2.03 $3.70 $1.94 $2.59 $2.81 $3.34 $2.21 $2.94 $3.16
Diluted shares 0.04B 0.04B 0.04B 0.04B 0.04B 0.04B 0.04B 0.04B 0.04B 0.04B
Cash flow
Cash from operations $184M $36.3M $83.5M $177M $219M $145M $12.1M $170M $157M $128M
Capital expenditure $81.2M $56.3M $50.7M $39.1M $52.2M $60.8M $79.3M $87.9M $59.2M $89.4M
Free cash flow $102M βˆ’$20.0M $32.8M $138M $167M $84.4M βˆ’$67.3M $81.8M $97.9M $38.4M
Depreciation and amortization $47.0M $48.5M $53.2M $55.0M $49.6M $52.1M $52.5M $57.8M $60.3M $61.1M
Stock-based compensation $7.7M $5.9M $0.5M βˆ’$0.7M $5.6M $9.6M $16.1M $8.9M $10.1M $13.9M
Acquisitions $0.0M $0.0M $31.1M $0.0M $0.0M $13.9M $22.7M $1.6M $0.0M $4.9M
Share buybacks $50.1M $87.2M $76.7M $0.0M $0.0M $42.5M $0.0M $0.0M $0.0M $0.0M
Dividends paid $49.6M $54.0M $57.4M $62.2M $66.1M $66.7M $68.9M $69.2M $69.4M $69.6M
Dividends and buybacks $99.7M $141M $134M $62.2M $66.1M $109M $68.9M $69.2M $69.4M $69.6M
Balance sheet
Cash and short-term investments $25.9M $29.3M $31.9M $21.2M $24.8M $25.7M $20.9M $28.9M $26.6M $36.5M
Total debt $604M $625M $710M $619M $536M $512M $631M $645M $614M $709M
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $717M $734M $823M $788M $742M $741M $935M $937M $962M $1.1B
Current liabilities $214M $216M $215M $201M $216M $232M $272M $236M $271M $264M
Inventory $404M $464M $491M $423M $381M $412M $564M $598M $600M $678M
Property and equipment, net $477M $499M $491M $437M $446M $447M $483M $505M $492M $539M
Total assets $1.7B $1.7B $1.8B $1.7B $1.7B $1.7B $2.0B $2.0B $2.0B $2.2B
Total liabilities $832M $872M $965M $859M $807M $807M $982M $961M $963M $1.1B
Shareholders' equity $836M $852M $860M $882M $934M $938M $1,000M $1.1B $1.1B $1.2B
Margins
Gross margin 36.1% 36.5% β€” β€” 31.8% 32.9% 34.0% 31.6% 32.6% 33.5%
Operating margin 13.1% 12.0% 14.7% 9.2% 11.5% 12.3% 13.7% 10.6% 12.3% 12.9%
EBITDA margin 16.4% 15.5% 18.5% 13.3% 15.2% 16.1% 17.3% 14.6% 16.2% 16.6%
Net margin 8.9% 6.4% 11.4% 6.2% 8.2% 8.6% 9.8% 6.4% 8.0% 8.3%
FCF margin 7.2% βˆ’1.4% 2.4% 10.4% 12.5% 6.1% βˆ’4.7% 5.6% 6.3% 2.4%
Returns
Return on capital 9.5% 7.1% 11.8% 6.5% 8.3% 8.9% 10.0% 6.8% 8.8% 8.9%
Return on capital employed 12.6% 11.3% 13.0% 7.7% 10.0% 11.2% 12.2% 8.9% 10.9% 11.1%
Return on equity 15.0% 10.6% 18.4% 9.4% 12.1% 12.7% 14.5% 9.1% 11.8% 11.9%
Return on assets 7.5% 5.3% 8.9% 4.6% 6.3% 6.8% 7.6% 4.7% 6.2% 6.3%
Growth
Revenue growth 0.6% βˆ’1.7% βˆ’0.7% βˆ’4.6% 0.7% 3.6% 4.1% 1.4% 6.9% 3.5%
Net income growth 18.2% βˆ’29.0% 75.6% βˆ’47.9% 33.4% 8.5% 18.7% βˆ’33.7% 33.5% 7.9%
EPS growth 22.1% βˆ’28.0% 82.3% βˆ’47.6% 33.5% 8.5% 18.9% βˆ’33.8% 33.0% 7.5%
FCF growth 112.9% βˆ’119.6% β€” 321.2% 20.7% βˆ’49.3% βˆ’179.7% β€” 19.7% βˆ’60.8%
Share count change βˆ’3.0% βˆ’1.8% βˆ’3.5% βˆ’0.5% 0.1% βˆ’0.2% βˆ’0.1% 0.1% 0.4% 0.5%
Financial health
Net debt / EBITDA 2.5x 2.8x 2.6x 3.4x 2.5x 2.2x 2.5x 2.9x 2.3x 2.5x
Debt / equity 0.7x 0.7x 0.8x 0.7x 0.6x 0.6x 0.6x 0.6x 0.6x 0.6x
Interest coverage 10.1x 8.7x 9.3x 6.0x 10.3x 13.6x 13.5x 6.2x 6.7x 7.0x
Current ratio 3.4x 3.4x 3.8x 3.9x 3.4x 3.2x 3.4x 4.0x 3.6x 4.1x
Quick ratio 1.5x 1.3x 1.6x 1.8x 1.7x 1.4x 1.4x 1.4x 1.3x 1.5x
Capital allocation
Capex / revenue 5.7% 4.0% 3.7% 3.0% 3.9% 4.4% 5.5% 6.0% 3.8% 5.6%
Stock comp / revenue 0.5% 0.4% 0.0% βˆ’0.1% 0.4% 0.7% 1.1% 0.6% 0.7% 0.9%
Payouts / FCF 97.4% β€” 409.2% 45.0% 39.7% 129.3% β€” 84.6% 70.9% 181.2%
Quality scores
Piotroski F-score 8.0 6.0 5.0 6.0 6.0 8.0 7.0 5.0 7.0 6.0
Altman Z'' 6.5 6.3 6.6 6.6 6.7 6.8 6.7 6.7 6.9 6.9
Accruals ratio βˆ’3.4% 3.1% 4.2% βˆ’5.3% βˆ’6.3% βˆ’1.5% 6.9% βˆ’3.8% βˆ’1.6% 0.3%

Source: SEC EDGAR XBRL filings (CIK 0000310142). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open